Kevin Bender is professor of neurology at the University of California, San Francisco. His lab focuses on understanding how the brain encodes information at the synaptic, cellular and network level. Work primarily revolves around understanding how ion channels and modulation of ion channels contribute to these processes in health and in neurodevelopmental and neuropsychiatric conditions. This includes studies related to neurodevelopmental channelopathies, for which he is grateful to be able to work with close colleagues and partners from academia, industry and patient advocacy groups.
Kevin Bender
Professor of neurology
University of California, San Francisco
From this contributor
Should I work with these people? A guide to collaboration
By
Kevin Bender
10 September 2024 | 7 min read
Selected articles
- “Impaired cerebellar plasticity hypersensitizes sensory reflexes in SCN2A-associated ASD” | Neuron
- “Physical and functional convergence of the autism risk genes Scn2a and Ank2 in neocortical pyramidal cell dendrites” | Neuron
- “Arrestin-3 Agonism at Dopamine D3 Receptors Defines a Subclass of Second-Generation Antipsychotics That Promotes Drug Tolerance” | Biological Psychiatry
- “The Autism-Associated Gene Scn2a Contributes to Dendritic Excitability and Synaptic Function in the Prefrontal Cortex” | Neuron
- “Periadolescent Maturation of GABAergic Hyperpolarization at the Axon Initial Segment” | Cell Reports
Explore more from The Transmitter
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
Autism scientists push back on CDC’s inaccurate vaccine claims
The CDC website now falsely suggests that autism-vaccine research is still an open question, prompting distrust among researchers—some of whom anticipate “more unreliable statements coming from the junta that took over” the agency.
By
The Transmitter
21 November 2025 | 6 min read
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
Gene replacement therapy normalizes some traits in SYNGAP1 model mice
The first published virus-based gene therapy for SYNGAP1 deletion yields benefits despite the gene’s long length and complexity.
By
Charles Q. Choi
20 November 2025 | 5 min read
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
Does AI understand what it produces? Henk de Regt explores how we might assess understanding in machines and humans
Building on his philosophy of how scientists understand what they work on, de Regt is extending his approach to test understanding in machines.
By
Paul Middlebrooks
19 November 2025 | 1 min read